World-Class Medicine. Personalized for Leukemia Patients. Up to 90% success rates in selected leukemia patients. FDA-approved CAR-T therapy. Delivered in one of the world’s most awarded hospital environments.
Leukemia is a complex and aggressive blood cancer. For some patients, chemotherapy, targeted drugs, or bone marrow transplantation may no longer provide sufficient results.
Unlike conventional treatments, CAR-T therapy is: • Personalized specifically for leukemia • Engineered from your own immune cells • Designed to precisely recognize and destroy leukemia cells
• Internationally recognized among the world’s most successful hospitals • Recipient of multiple global healthcare excellence awards • Applying Europe’s most advanced leukemia treatment protocols • Fully Joint Commission International (JCI) accredited • Delivered under FDA-approved CAR-T therapy frameworks This is not standard leukemia treatment. This is precision medicine at the highest level.
CAR-T Cell Therapy has shown remarkable results particularly in: • Acute Lymphoblastic Leukemia (ALL) • Certain relapsed or refractory leukemias • Leukemia cases resistant to chemotherapy • Patients who relapsed after stem cell transplantation Clinical studies and real-world data demonstrate success rates of up to 90% in selected leukemia patients.
1️⃣ Advanced Leukemia Evaluation Your journey begins with a comprehensive medical, genetic, and molecular evaluation focused specifically on your leukemia subtype. 2️⃣ Personalized Leukemia Cell Engineering Your own T cells are collected and reprogrammed in advanced biotechnology laboratories to recognize and eliminate leukemia cells with high precision. 3️⃣ Controlled Treatment & Continuous Monitoring CAR-T cells are administered in a specialized clinical setting, followed by close monitoring and personalized follow-up by experienced leukemia specialists.
✔ Targets leukemia cells with exceptional precision ✔ Uses your own immune system ✔ Reduces damage to healthy cells compared to chemotherapy ✔ Offers new hope for relapsed or treatment-resistant leukemia ✔ One-time, personalized cellular therapy approach You are not adapting to a leukemia treatment. The treatment is adapted to your leukemia.
✔ World-class hospital infrastructure ✔ International awards & global medical recognition ✔ FDA-approved CAR-T therapy pathways ✔ Europe’s most advanced leukemia treatment protocols ✔ Ethical, transparent, patient-centered approach ✔ Dedicated international patient coordination team
CAR-T Cell Therapy may be suitable if you: • Have leukemia that has not responded to standard treatments • Have experienced relapse • Are seeking an advanced, personalized leukemia therapy • Want access to globally recognized medical excellence Every leukemia case is reviewed individually by our medical team.
The future of cancer care is here. Discover our research into novel gene therapies and combinations.
-small.avif)
Tailoring medical strategies to your unique genetic profile and tumor biology for maximum efficacy.
Specialized care for Leukemia, Lymphoma, and Myeloma using the latest cellular technologies.
Using tumor-infiltrating lymphocytes to fight solid tumors, offering new hope for metastatic cancers.
Reprogramming T-cells to identify and eliminate cancer cells with precision. Effective for leukemia and lymphoma.
Nowadays, patients have plenty of options when it comes to choosing a place where they can receive care, and it is vital to make an informed decision. You Immunology, recognized as the Best Hospital in Turkey, is an international leader in cellular immunotherapy, collaborating with global health centers to develop groundbreaking techniques and life-saving treatments.
Our all-inclusive medical facility features world-class laboratories and clinics, treating thousands of international patients annually. While constantly improving the first-class medicine and services provided at You Immunology, we never lose sight of what matters – the individual, and are deeply committed to delivering patient-centric, compassionate, and personalized care.
CAR T-cell therapy is an advanced immunotherapy in which a patient’s own T cells are genetically modified to better recognize and attack cancer cells, then reinfused back into the body.
It is primarily used for certain blood cancers, including specific types of leukemia and lymphoma. It is FDA-approved and shows high response rates in eligible patients.
Success varies by cancer type, but in some forms of leukemia, response rates can reach up to 90%.
TIL (Tumor-Infiltrating Lymphocyte) therapy is an immunotherapy approach in which a patient’s own immune cells are harvested, expanded in the laboratory, and reinfused to fight cancer.
No. TIL therapy is currently used more commonly in certain solid tumors, especially metastatic melanoma. Patient suitability is determined on an individual basis.
Its personalized nature and its ability to strengthen the immune system in a targeted way are considered its main advantages.
Dr. Ercüment Ovalı is a renowned Turkish scientist recognized for his pioneering work in molecular biology, stem cell research, and regenerative medicine. With decades of academic and clinical experience, he focuses on translating scientific innovation into patient-centered therapeutic approaches.
His work emphasizes evidence-based medicine, personalized treatment strategies, and the ethical advancement of regenerative therapies, aiming to improve patient outcomes through science-driven healthcare solutions.
Need more information?
Revolutionizing cancer treatment with CAR-T cell engineering and personalized immunological solutions
Folkart Time Bornova Sitesi, Kazımdirik, 284. Sk. No:2 D:613, 35100 Bornova/İzmir, Turkey
